 Home > Medical News > Latest Medical News > The data said: The second round of centralized procurement was implemented for one year, what impact did it bring to the market, and why did the volume and price of generic drugs fall?

The data said: The second round of centralized procurement was implemented for one year, what impact did it bring to the market, and why did the volume and price of generic drugs fall?

 Last Update: 2021-07-28
 Source: Internet
 Author: User

Tags

particle size analysis

what batch number

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

According to official data, the average price of the second round of centralized procurement has dropped by 53%.
Today, the second round of centralized procurement has been implemented for nearly a year.
What impact will the second round of centralized procurement have on the pharmaceutical market?

Using the sales data analysis in 2020 (refer to the admission price of IMS), the total sales of more than 30 varieties selected in the second round of centralized procurement will be 29.
413 billion yuan in 2020.
Compared with the 40.
507 billion yuan in 2019, the market size has shrunk by 27.
39.
%, total sales dropped from 14.
598 billion doses in 2019 to 13.
939 billion doses, a shrink of 4.
51%
.

The total sales of original research drugs decreased from 18.

On the hospital side, the total sales of more than 30 varieties selected in the first round of centralized procurement in 2020 will be 23.
563 billion yuan.
Compared with the 33.
957 billion yuan in 2019, the market size has shrunk by 30.
61%, and the total sales volume has increased from 90.
89 in 2019.
100 million doses dropped to 8.
804 billion doses, a shrinkage of 3.
14%
.

The total sales of original research drugs dropped from 15.

On the retail side, the total sales of more than 30 varieties selected in the first round of centralized procurement in 2020 will be 5.
85 billion yuan.
Compared with the 6.
55 billion yuan in 2019, the market size has shrunk by 10.
69%, and the total sales volume has increased from 55.
09 in 2019.
100 million doses dropped to 5.
135 billion doses, a shrinkage of 6.
79%
.

The total sales of original research drugs decreased from 2.

Based on the above data, the total market size of generic drugs shrank by 21.
22%, of which the hospital market shrank by 24.
01%, and the retail end shrank by 8.
12%.
In terms of sales, total sales fell by 5.
99%, of which the hospital end fell by 4.
02%, and the retail end fell by 8.
84%.
All prices fell
.

As for the reasons for the above data, there may be multiple reasons

Changes in sales of the second batch of centralized procurement varieties

Changes in sales of the second batch of centralized procurement of original research varieties

The above data and analysis are for reference only and do not represent any official opinions

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.